Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Jamaica
(0/week)
Netherlands Antilles
(0/week)
View all
(0/week)
News
United States
(1352/week)
Manufacturing
(704/week)
Technology
(1308/week)
Energy
(520/week)
Other Manufacturing
(406/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
IDEAYA Biosciences, Inc.
Apr 22, 2024
IDEAYA Biosciences Announces Selection of Move-Forward Phase 2 Expansion Dose for IDE397 Monotherapy in MTAP-Deletion Squamous Non-Small Cell Lung Cancer
Apr 05, 2024
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Apr 01, 2024
IDEAYA Biosciences to Participate in Upcoming April 2024 Investor Relations Event
Mar 12, 2024
IDEAYA Announces Clinical Collaboration to Evaluate IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer
Mar 04, 2024
IDEAYA Biosciences to Participate in Upcoming March 2024 Investor Relations Events
Jan 07, 2024
IDEAYA Biosciences Announces Participation at the 42nd Annual J.P. Morgan Healthcare Conference and 2024 Corporate Guidance
Feb 17, 2021
IDEAYA Biosciences Appoints Susan L. Kelley, M.D., an Industry Veteran in Medical Oncology and Clinical Development, to its Board of Directors
Feb 08, 2021
IDEAYA Announces IDE397 IND Clearance by U.S. FDA to Initiate Phase 1 and Appointment of Matthew Maurer, M.D., as Vice President, Head of Clinical Oncology and Medical Affairs
Feb 01, 2021
IDEAYA to Participate in Upcoming February 2021 Investor Relations Events
Jan 19, 2021
Spelman College and IDEAYA Biosciences Announce Partnership for Professional Development of the Next Generation of Female African American Leaders in the Biotechnology Industry
Jan 11, 2021
IDEAYA Biosciences Announces Submission of IND Application for MAT2A Development Candidate IDE397 with the U.S. FDA
Jan 05, 2021
IDEAYA Biosciences Doses First Patient in a Phase 1 Combination Study of IDE196 and Crizotinib, a cMET Inhibitor
Jan 04, 2021
IDEAYA to Participate in Upcoming January 2021 Investor Relations Events and Scientific Conferences
Dec 14, 2020
IDEAYA Biosciences Announces Addition to NASDAQ Biotechnology Index
Nov 12, 2020
IDEAYA Biosciences, Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update
Nov 02, 2020
IDEAYA to Participate in Upcoming November 2020 Investor Relations Events
Oct 22, 2020
IDEAYA Announces Partnership With The Broad Institute And Advancement Of Synthetic Lethality Programs And Platform
Sep 24, 2020
IDEAYA and Pfizer Expand Clinical Trial Collaboration and Supply Agreement to Evaluate Clinical Combination of IDE196 and Crizotinib in Solid Tumors Harboring GNAQ or GNA11 Mutations
Aug 31, 2020
IDEAYA to Participate in Upcoming September 2020 Investor Relations Events
Aug 12, 2020
IDEAYA Biosciences, Inc. Reports Second Quarter 2020 Financial Results and Provides Business Update
‹‹
Page 4
››
Latest News
Oct 17, 2025
Exchange Income Corporation Announces October 2025 Dividend
Oct 17, 2025
Cincoze Launches New MAGNET Product Line – High-Performance DIN-Rail Embedded Computers for Machine Vision
Oct 17, 2025
New Era Energy & Digital, Inc. Terminates EPFA and Withdraws Preliminary Proxy Statement
Oct 17, 2025
SLB Announces Third-Quarter 2025 Results
Oct 17, 2025
Ferguson Enterprises Inc. (“Company”): Director/PDMR Shareholding
Oct 17, 2025
Customer Commitment Powers VinFast’s Rise in EV Market
Oct 17, 2025
Black Rifle Coffee Company Announces Dates for Its Third Quarter 2025 Earnings Release and Conference Call
Oct 17, 2025
Circus SE Set for High-Volume Market Entry in the Defense Sector
View all News
Agenda
06
May
United Kingdom
London, UK
C4ISR GLOBAL 2026, 6-7 May 2026, London, UK
Defence iQ Announces return of C4ISR Global 2026 in Collaboration with Space Operations. London, UK – Defence iQ is...
27
January
United States of America
The Westin Arlington, Arlington, VA
Future Indirect Fires, January 27-28, 2026, The Westin Arlington, Arlington, VA
Future Indirect Fires, January 27-28, 2026, The Westin Arlington, Arlington, VA Supporting Next-Generation Capability...
03
December
United Kingdom
Copthorne Tara Hotel, London, UK
Uncrewed & Autonomous Systems, 3 - 4 December 2025, Copthorne Tara Hotel, London, UK
Uncrewed & Autonomous Systems | 3 - 4 December 2025| Copthorne Tara Hotel, London, UK Uncrewed & Autonomous...
View All Events